Net Cash Provided by (Used in) Operating Activities |
1.33B |
USD |
-6.39% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-269M |
USD |
-4.67% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-751M |
USD |
+41.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
800M |
shares |
0% |
Q4 2024 |
FY 2024 |
Common Stock, Shares, Issued |
291M |
shares |
+62.8% |
Q4 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
314M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
164M |
USD |
-72% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
119M |
USD |
-48.9% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
485M |
USD |
+6.36% |
Q4 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
52M |
USD |
-46.4% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
225M |
USD |
-4.66% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
2.85B |
USD |
+63.2% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
366M |
USD |
+64.1% |
Q4 2024 |
FY 2024 |